Alice R T Bergin

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Endoplasmic Reticulum

Metastatic Breast Cancer

Epidermal Growth Factor Receptor

Top Venues

Cancer immunology research

JCO global oncology

Cancer discovery

Asia-Pacific journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Alice R T Bergin, Roberto Salgado, Sherene Loi
Ethnicity, Immunity, and Outcomes: Biology versus Socioeconomic Status. Cancer immunology research (2023)
Alice R T Bergin, Roberto Salgado, Sherene Loi
Ethnicity, Immunity, and Outcomes: Biology versus Socioeconomic Status. Cancer immunology research 11 (6) (2023)
Alice R T Bergin
Insights Into the Demands on a Clinical Oncologist in Sri Lanka. JCO global oncology 8 (2022)
Alice R T Bergin, Stephen J Luen, Peter Savas, Vishal Boolell, Doah Cho, Jodi Lynch, Louise Nott, Robin Stuart-Harris, Lee Na Teo, Saw Yee Yap, Sherene Loi
Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer: An Australian case series. Asia-Pacific journal of clinical oncology 15 (6) (2019)
Alice R T Bergin, Sherene Loi
Triple-negative breast cancer: recent treatment advances. F1000Research 8 (2019)
Sheau W Lok, James R Whittle, François Vaillant, Charis E Teh, Louisa L Lo, Antonia N Policheni, Alice R T Bergin, Jayesh Desai, Sarah Ftouni, Luke C Gandolfo, Danny Liew, He K Liu, G Bruce Mann, Kate Moodie, Anand Murugasu, Bhupinder Pal, Andrew W Roberts, Mark A Rosenthal, Kylie Shackleton, Maria João Silva, Zhen R Siow, Aaron T L Lun, Leanne Taylor, Avraham Travers, Belinda Yeo, Miriam M Yeung, Andjelija Zivanovic Bujak, Sarah-Jane Dawson, Daniel H D Gray, Jane E Visvader, Geoffrey J Lindeman
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer. Cancer discovery 9 (3) (2018)